दवाओं की अंतःक्रिया
Erdafitinib + Sevelamer
गंभीरता: मध्यम
Erdafitinib and Sevelamer: moderate interaction.
अंतिम अपडेट
केवल स्वास्थ्य पेशेवरों के लिए — मात्र संदर्भ हेतु। यह पृष्ठ संक्षिप्त सारांश है, चिकित्सकीय सलाह नहीं है और आधिकारिक लेबल या नैदानिक निर्णय का विकल्प नहीं है। दवा लिखने या देने से पहले हमेशा जाँच करें।
इस पृष्ठ की नैदानिक सामग्री केवल अंग्रेज़ी में उपलब्ध है।
सारांश
Erdafitinib raises serum phosphate as an expected effect of FGFR inhibition, and this level guides dose escalation during the first weeks of treatment. A phosphate binder such as sevelamer can mask this rise and lead to inappropriate dosing decisions.
इस इंटरैक्शन का सरल भाषा में अर्थ
Erdafitinib and Sevelamer can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Erdafitinib belongs to Oncology; Sevelamer belongs to Miscellaneous.
ऐसा क्यों होता है
Pharmacodynamic confounding: sevelamer binds dietary phosphate and lowers serum phosphate, obscuring the phosphate response used to titrate erdafitinib.
क्या करें
Avoid phosphate binders during the first 21 days of erdafitinib so the phosphate-guided dose titration is reliable. Afterward, use binders only if hyperphosphatemia needs management according to labeling.
फार्मासिस्ट से क्या पूछें
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ सदस्यों के लिए
पूरा पेज खोलें
Erdafitinib और Sevelamer की पूरी प्रबंधन सलाह, अतिरिक्त नोट्स, साक्ष्य का विवरण और पूरे पर्चे का इंटरैक्शन चेकर खोलने के लिए खाता बनाएँ और Pro+ ट्रायल शुरू करें।
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
वेब पर Pro+ को 14 दिन मुफ़्त आज़माएँ। कार्ड की ज़रूरत नहीं।
Sevelamer के अन्य इंटरैक्शन
Erdafitinib के अन्य इंटरैक्शन
अक्सर पूछे जाने वाले प्रश्न
Can I take Erdafitinib with Sevelamer?
MediHelp rates the interaction as moderate. Erdafitinib and Sevelamer can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Erdafitinib raises serum phosphate as an expected effect of FGFR inhibition, and this level guides dose escalation during the first weeks of treatment. A phosphate binder such as sevelamer can mask this rise and lead to inappropriate dosing decisions.
How serious is the interaction between Erdafitinib and Sevelamer?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid phosphate binders during the first 21 days of erdafitinib so the phosphate-guided dose titration is reliable. Afterward, use binders only if hyperphosphatemia needs management according to labeling.
What other medicines interact with Sevelamer?
MediHelp also lists interactions of Sevelamer with, for example, Carbamazepine, Ciprofloxacin, Dichlorphenamide. The full list is on the Sevelamer page.
MediHelp ऐप में पूर्ण मोनोग्राफ़, खुराक और इंटरैक्शन चेकर
MediHelp ऐप में पूरा संदर्भ खोलें, कई दवाओं की अंतःक्रियाएँ जाँचें और खुराक टूल इस्तेमाल करें।
